(Q33956671)

30 July 2017

1 reference

title

The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control (English)

1 reference

30 July 2017

Decker MW

1

1 reference

30 July 2017

Meyer MD

series ordinal

2

1 reference

30 July 2017

Sullivan JP

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

1 reference

30 July 2017

10

1 reference

30 July 2017

10

1 reference

30 July 2017

1819-1830

1 reference

Cyclooxygenase 2 inhibitors: discovery, selectivity and the future

30 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Emerging molecular approaches to pain therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

The promise and pitfalls of a nicotinic cholinergic approach to pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Human neuronal nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

The TiPS lecture. The nicotinic acetylcholine receptor: an allosteric protein prototype of ligand-gated ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

The molecular biology of neuronal nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

The alpha-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the alpha7 subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Neuronal nicotinic acetylcholine receptors in rat trigeminal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Epibatidine: high potency and broad spectrum activity on neuronal and neuromuscular nicotinic acetylcholine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Nicotinic cholinergic receptors: potential targets for inflammatory pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Antihyperalgesic activity of epibatidine in the formalin model of facial pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Conformationally restricted analogues of nicotine and anabasine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Synthesis, optical resolution, absolute configuration, and preliminary pharmacology of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H- pyrrolo-[3,2-h]isoquinoline, a structural analog of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Protective effect of GTS-21, a novel nicotinic receptor agonist, on delayed neuronal death induced by ischemia in gerbils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Evaluation of anti-nociceptive effects of neuronal nicotinic acetylcholine receptor (NAChR) ligands in the rat tail-flick assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Reduced antinociception in mice lacking neuronal nicotinic receptor subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

The antinociception produced by microinjection of a cholinergic agonist in the ventromedial medulla is mediated by noradrenergic neurons in the A7 catecholamine cell group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

The role of neuronal nicotinic acetylcholine receptors in antinociception: effects of ABT-594.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Epibatidine binding sites and activity in the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Sex differences in cholinergic analgesia I: a supplemental nicotinic mechanism in normal females

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Presynaptic nicotinic ACh receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

The involvement of spinal Ca(2+)/calmodulin-protein kinase II in nicotine-induced antinociception in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Pharmacological effects of epibatidine optical enantiomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Transdermal nicotine: reduction of smoking with minimal abuse liability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Nicotine-induced place preferences following prior nicotine exposure in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

Sex differences in cocaine- and nicotine-induced antinociception in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.10.1819

10.1517/13543784.10.10.1819

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference